Delfi Limited (SGX:P34)
Singapore · Delayed Price · Currency is SGD 0.7750
-0.0750 (-8.82%)
Aug 13, 2025, 5:04 PM SGT
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 26.57 | 33.95 | 46.26 | 43.9 | 29.28 | 17.48 | Upgrade |
Depreciation & Amortization | 13.29 | 12.37 | 10.72 | 10.48 | 12.24 | 12.5 | Upgrade |
Other Amortization | 0.16 | 0.16 | 0.26 | 1.31 | 1.35 | 1.27 | Upgrade |
Loss (Gain) From Sale of Assets | -0.06 | -0.08 | -0.23 | -0.32 | -0.63 | -0.05 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 0.05 | - | - | Upgrade |
Loss (Gain) on Equity Investments | 0.08 | 0.09 | 0.31 | 0.16 | 0.19 | 0.39 | Upgrade |
Other Operating Activities | 0.11 | -4.65 | -5.2 | 2.68 | 5.1 | -2.14 | Upgrade |
Change in Accounts Receivable | -12.88 | 9.55 | -16.57 | -5.37 | 13.92 | 10.45 | Upgrade |
Change in Inventory | -4.61 | -15.93 | -0.44 | -50.61 | 12.01 | 10.55 | Upgrade |
Change in Accounts Payable | 49.83 | 16.87 | -10.85 | 4.76 | 4.46 | -11.42 | Upgrade |
Change in Other Net Operating Assets | 0.08 | 0.24 | 1.05 | 0.72 | -0.72 | 3.37 | Upgrade |
Operating Cash Flow | 72.56 | 52.57 | 25.3 | 7.74 | 77.19 | 42.41 | Upgrade |
Operating Cash Flow Growth | 83.98% | 107.83% | 226.71% | -89.97% | 82.02% | 32.16% | Upgrade |
Capital Expenditures | -8.24 | -28.6 | -23.59 | -3.78 | -3.14 | -4.48 | Upgrade |
Sale of Property, Plant & Equipment | 0.06 | 0.21 | 0.27 | 0.33 | 3.18 | 0.08 | Upgrade |
Sale (Purchase) of Intangibles | -0.3 | -0.34 | -0.15 | -0.17 | -0.24 | -0.44 | Upgrade |
Investment in Securities | -0.08 | -0.07 | -0.5 | - | - | - | Upgrade |
Investing Cash Flow | -8.56 | -28.79 | -23.97 | -3.61 | -0.2 | -4.84 | Upgrade |
Long-Term Debt Issued | - | - | 15.3 | 8.24 | - | - | Upgrade |
Total Debt Issued | -4 | - | 15.3 | 8.24 | - | - | Upgrade |
Long-Term Debt Repaid | - | -6.96 | -7.76 | -1.53 | -39.27 | -10.55 | Upgrade |
Total Debt Repaid | -8.79 | -6.96 | -7.76 | -1.53 | -39.27 | -10.55 | Upgrade |
Net Debt Issued (Repaid) | -12.79 | -6.96 | 7.55 | 6.71 | -39.27 | -10.55 | Upgrade |
Common Dividends Paid | -16.77 | -23.37 | -24.66 | -16.26 | -14.29 | -14.51 | Upgrade |
Other Financing Activities | -1.26 | -1.42 | -1.22 | -0.63 | -1.18 | -3.15 | Upgrade |
Financing Cash Flow | -33.99 | -34.93 | -22.73 | -13.12 | -54.74 | -28.21 | Upgrade |
Foreign Exchange Rate Adjustments | -0.17 | -0.38 | 0.66 | -1.2 | -0.8 | -0.25 | Upgrade |
Net Cash Flow | 29.84 | -11.53 | -20.74 | -10.19 | 21.45 | 9.1 | Upgrade |
Free Cash Flow | 64.32 | 23.98 | 1.7 | 3.97 | 74.05 | 37.92 | Upgrade |
Free Cash Flow Growth | 1636.97% | 1307.99% | -57.08% | -94.64% | 95.26% | 73.16% | Upgrade |
Free Cash Flow Margin | 12.83% | 4.77% | 0.32% | 0.83% | 18.28% | 9.85% | Upgrade |
Free Cash Flow Per Share | 0.10 | 0.04 | 0.00 | 0.01 | 0.12 | 0.06 | Upgrade |
Cash Interest Paid | 1.42 | 1.42 | 1.22 | 0.63 | 1.06 | 3.15 | Upgrade |
Cash Income Tax Paid | 21.21 | 21.21 | 25.63 | 17.07 | 10.73 | 15.44 | Upgrade |
Levered Free Cash Flow | 52.03 | 14.06 | -8.54 | 6.71 | 74.4 | 35.47 | Upgrade |
Unlevered Free Cash Flow | 52.81 | 14.94 | -7.78 | 7.1 | 75.06 | 37.44 | Upgrade |
Change in Working Capital | 32.42 | 10.74 | -26.82 | -50.51 | 29.66 | 12.96 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.